Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Humana (NY: HUM )

288.12 +0.36 (+0.13%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Humana and Evolent Expand Partnership to Enhance Oncology Care
From Evolent Health, Inc.
Via Business Wire
Unpacking the Latest Options Trading Trends in Humana
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Latest Analyst Ratings For Humana
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have $700 Today
Via Benzinga
Unpacking the Latest Options Trading Trends in Humana
Via Benzinga
MarketBeat Week in Review – 10/28 - 11/1
Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Humana Lifts 2024 Profit Outlook As Q3 Earnings Beat Street View On Medicare Strength
Humana's Q3 EPS of $4.16 beat estimates but fell year-over-year. Revenue rose to $29.3 billion, driven by Medicare Advantage growth. 2024 guidance raised. 
Via Benzinga
Topics Earnings
Exposures Financial
Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance
From Humana Inc.
Via Business Wire
HUM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Humana Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Unpacking the Latest Options Trading Trends in Humana
Via Benzinga
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
HUM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Humana Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Large-Cap Stocks In Trouble - Sunday, Oct. 27
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Humana Board Declares Payment of Quarterly Dividend to Stockholders
From Humana Inc.
Via Business Wire
Humana Named “Best-of-the-Best” Company for Supplier Diversity by the National LGBT Chamber of Commerce
From Humana Inc.
Via Business Wire
Humana and Longevity Health Multi-State Agreement Expands Access to Humana Together in Health Special Needs Plans
From Humana Inc.
Via Business Wire
Humana Elects Gordon Smith to Board of Directors
From Humana Inc.
Via Business Wire
CenterWell Home Health Collects Nearly 90,000 Meals for Needy
From Humana Inc.
Via Business Wire
HUMANA ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Humana Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Cigna Group Stock Got Mashed on Monday
A media report stated that the company is determined to grow with a major merger deal. 
Via The Motley Fool
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
U.S. major indices fell on Monday as rising Treasury yields and a strengthening dollar dampened risk sentiment. Investors are reassessing the economic outlook and weighing potential risks tied to the... 
Via Benzinga
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue. 
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
Market Briefing For Monday, Oct 21
Investors need to recognize that this time of year not only are more 'shakeouts' than we've seen likely; but tax-selling and shuffling (rearranging the Titanic deckchairs to some degree) is to be... 
Via Talk Markets
SAP, Nucor And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Large-Cap Stocks In Trouble - Saturday, Oct. 19
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Humana Receives High Rankings on the 2024 Hispanic Association on Corporate Responsibility Corporate Inclusion Index
From Humana Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.